Role of the Canadian Radiation Oncology Foundation in the funding ecosystem
The Canadian Radiation Oncology Foundation (CROF) is a registered charitable foundation created to support and extend the work of the Canadian Association of Radiation Oncology (CARO). Its core purpose is to raise and distribute funds to advance radiation medicine in Canada. CROF invests in professional education, scientific research and public education initiatives that improve access to high‑quality radiation oncology care and reduce the burden of cancer for patients nationwide.
CROF concentrates its support on several key themes: professional training and development for radiation oncologists and related professionals; interdisciplinary collaboration; advancing the contribution of radiation therapy in cancer care; increasing public awareness of radiation treatment; and preparing the next generation of radiation oncologists. Funding is directed to structured awards, studentships, travel grants and other educational activities managed in partnership with CARO.
Types of funding and main audiences
CROF primarily supports trainees and early‑career professionals in radiation oncology. Programs highlighted on the CARO/CROF site include the CARO–CROF Pamela Catton Summer Studentship Award, which places Canadian medical students in radiation oncology centres for clinical exposure, research opportunities, mentoring and career counselling. The CROF Resident Elective or Resident Career Travel Award helps senior residents explore practice opportunities in Canadian centres, recognizing geographic disparities in workforce distribution.
Other CARO–CROF initiatives include travel grants for radiation therapists to attend CARO’s Annual Scientific Meeting, and scholarships such as the Global Health Scholarship, which provides financial assistance toward travel and living expenses for residents or fellows undertaking electives in resource‑limited settings. Collectively, these instruments function as targeted grants that relieve financial barriers to advanced training, mobility and scholarly activity in radiation oncology.
General approach to evaluation and impact
While detailed selection criteria are handled within each specific award program, the foundation’s mission and values indicate its overarching priorities. CROF favours projects and individuals that contribute to professional excellence, foster collaborative practice, expand the role of radiation therapy in comprehensive cancer care and enhance public understanding of radiation oncology. Emphasis is placed on supporting the younger generation of radiation oncologists through studentships, elective travel and career development opportunities.
The impact of CROF’s funding is visible through a history of co‑branded CARO–CROF awards, past fellowships and research grants, as well as donor‑funded initiatives that have provided substantial grant monies for prostate cancer research, radiotherapy innovation and international oncology collaboration. Donor recognition walls and annual fundraising events such as the CROF Run/Walk underscore the foundation’s role as a conduit between philanthropic support and concrete financial assistance for education and research.
Governance, partnerships and transparency
CROF is overseen by a Foundation Board of Directors composed of radiation oncologists and leaders from across Canada, including a chair, treasurer, secretary, directors and a resident/fellow representative. The foundation works in close partnership with CARO and with industry and institutional collaborators that co‑sponsor awards and fellowships. Core values such as respect for donors, clear communication, integrity, transparency, professionalism, accountability and teamwork guide how funds are raised, allocated and reported.
Through these structures and values, the Canadian Radiation Oncology Foundation plays a specialized role in Canada’s health research and education funding ecosystem, channeling charitable contributions into multiple recurring grant programs that strengthen radiation oncology capacity and ultimately benefit cancer patients across the country.